Masimo Share Price (NASDAQ: MASI)

$139.57

▲

-1.38

(-0.98%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Masimo Stock chart to analyse performance

Masimo stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$138.91
Today's High:$141.00
$139.57
0.47%
Downside
Day's Volatility :1.48%
Upside
1.01%
52 Weeks Low:$107.98
52 Weeks High:$194.88
$139.57
22.63%
Downside
52 Weeks Volatility :44.59%
Upside
28.38%

Masimo Stock Returns

Period	Masimo Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	-15.28%	3.6%	0.0%
6 Months	-26.66%	-7.7%	0.0%
1 Year	22.62%	-12.6%	0.0%
3 Years	-4.35%	9.5%	-4.7%

Masimo Corp Key Stats

Check Masimo key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$140.95
Open	$141.0
Today's High	$141.0
Today's Low	$138.91
Market Capitalization	$7.7B
Today's Volume	$459.9K
52 Week High	$194.88
52 Week Low	$107.98
Revenue TTM	$2.2B
EBITDA	$153.8M
Earnings Per Share (EPS)	$-5.09
Profit Margin	-21.32%
Quarterly Earnings Growth YOY	2.14%
Return On Equity TTM	-22.37%

Stock Returns calculator for Masimo Stock including INR - Dollar returns

The Masimo stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Masimo investment value today

Current value as on today

₹1,24,047

Returns

₹24,047

(+24.05%)

Returns from Masimo Stock

₹18,763 (+18.76%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Masimo Stock

67%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Masimo Stock from India on INDmoney has increased by 67% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Masimo Corp

Name
Holdings %
Name
Holdings %
BlackRock Inc
18.17%
FMR Inc
15.06%
Politan Capital Management LP
8.68%
Vanguard Group Inc
8.54%
T. Rowe Price Investment Management,Inc.
4.60%
Massachusetts Financial Services Company
4.55%

Analyst Recommendation on Masimo Stock

Rating

Trend

Buy

66%Buy

33%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Masimo(by analysts ranked 0 to 5 stars)

Masimo Share Price Target

What analysts predicted

Upside of 34.39%

Target:

$187.57

Current:

$139.57

Masimo share price target is $187.57, a slight Upside of 34.39% compared to current price of $139.57 as per analysts' prediction.

Masimo Stock Insights

Price Movement
In the last 7 days, MASI stock has moved down by -5.9%
Decreasing Revenue
Revenue is down for the last 3 quarters, 600.7M → 370.9M (in $), with an average decrease of 19.2% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -349.6M → 51.3M (in $), with an average increase of 268.8% per quarter
MASI vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 29.0% return, outperforming this stock by 10.0%
MASI vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 163.5% return, outperforming this stock by 170.0%
Price to Sales
ForMASI every $1 of sales, investors are willing to pay $3.5, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Masimo Corp Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$937.8M	↑ 9.27%
Net Income	$196.2M	↑ 1.38%
Net Profit Margin	20.92%	↓ 1.63%

	FY20	Y/Y Change
Revenue	$1.1B	↑ 21.96%
Net Income	$240.3M	↑ 22.47%
Net Profit Margin	21.01%	↑ 0.09%

	FY21	Y/Y Change
Revenue	$1.2B	↑ 8.34%
Net Income	$229.6M	↓ 4.45%
Net Profit Margin	18.53%	↓ 2.48%

	FY22	Y/Y Change
Revenue	$2.0B	↑ 64.29%
Net Income	$143.5M	↓ 37.5%
Net Profit Margin	7.05%	↓ 11.48%

	FY23	Y/Y Change
Revenue	$2.0B	↑ 0.6%
Net Income	$81.5M	↓ 43.21%
Net Profit Margin	3.98%	↓ 3.07%

	FY24	Y/Y Change
Revenue	$2.1B	↑ 2.26%
Net Income	$-304.9M	↓ 474.11%
Net Profit Margin	-14.56%	↓ 18.54%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$492.8M	↓ 10.22%
Net Income	$18.9M	↓ 44.25%
Net Profit Margin	3.84%	↓ 2.34%

	Q2 FY24	Q/Q Change
Revenue	$496.3M	↑ 0.71%
Net Income	$16.0M	↓ 15.34%
Net Profit Margin	3.22%	↓ 0.62%

	Q3 FY24	Q/Q Change
Revenue	$504.6M	↑ 1.67%
Net Income	$9.8M	↓ 38.75%
Net Profit Margin	1.94%	↓ 1.28%

	Q4 FY24	Q/Q Change
Revenue	$600.7M	↑ 19.04%
Net Income	$-349.6M	↓ 3667.35%
Net Profit Margin	-58.2%	↓ 60.14%

	Q1 FY25	Q/Q Change
Revenue	$372.0M	↓ 38.07%
Net Income	$-170.7M	↓ 51.17%
Net Profit Margin	-45.89%	↑ 12.31%

	Q2 FY25	Q/Q Change
Revenue	$370.9M	↓ 0.3%
Net Income	$51.3M	↓ 130.05%
Net Profit Margin	13.83%	↑ 59.72%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$629.2M	↑ 9.44%

	FY20	Y/Y Change
Profit	$743.1M	↑ 18.1%

	FY21	Y/Y Change
Profit	$808.3M	↑ 8.79%

	FY22	Y/Y Change
Profit	$1.1B	↑ 30.98%

	FY23	Y/Y Change
Profit	$1.0B	↓ 5.22%

	FY24	Y/Y Change
Profit	$1.0B	↑ 0.09%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$241.7M	↓ 7.99%

	Q2 FY24	Q/Q Change
Profit	$254.8M	↑ 5.42%

	Q3 FY24	Q/Q Change
Profit	$263.2M	↑ 3.3%

	Q4 FY24	Q/Q Change
Profit	$244.7M	↓ 7.03%

	Q1 FY25	Q/Q Change
Profit	$234.0M	↓ 4.37%

	Q2 FY25	Q/Q Change
Profit	$233.3M	↓ 0.3%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$221.6M	↓ 7.47%
Investing Cash Flow	$-197.7M	↑ 655.89%
Financing Cash Flow	$-9.3M	↓ 136.23%

	FY20	Y/Y Change
Operating Cash Flow	$211.0M	↓ 4.82%
Investing Cash Flow	$-82.8M	↓ 58.12%
Financing Cash Flow	$-54.3M	↑ 481.51%

	FY21	Y/Y Change
Operating Cash Flow	$264.8M	↑ 25.5%
Investing Cash Flow	$-37.5M	↓ 54.67%
Financing Cash Flow	$-122.4M	↑ 125.39%

	FY22	Y/Y Change
Operating Cash Flow	$29.5M	↓ 88.86%
Investing Cash Flow	$-1.1B	↑ 2718.09%
Financing Cash Flow	$520.3M	↓ 525.07%

	FY23	Y/Y Change
Operating Cash Flow	$94.1M	↑ 218.98%
Investing Cash Flow	$-81.2M	↓ 92.32%
Financing Cash Flow	$-57.1M	↓ 110.97%

	FY24	Y/Y Change
Operating Cash Flow	$196.4M	↑ 108.71%
Investing Cash Flow	$-51.2M	↓ 36.95%
Financing Cash Flow	$-125.6M	↑ 119.96%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$45.8M	↓ 40.6%
Investing Cash Flow	$-18.9M	-
Financing Cash Flow	$-26.5M	↓ 27.0%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$74.5M	↑ 62.66%
Investing Cash Flow	$-2.3M	↓ 87.83%
Financing Cash Flow	$-91.0M	↑ 243.4%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$25.6M	↓ 65.64%
Investing Cash Flow	$-13.5M	↑ 486.96%
Financing Cash Flow	$-1.6M	↓ 98.24%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$50.5M	↑ 97.27%
Investing Cash Flow	$-16.5M	↑ 22.22%
Financing Cash Flow	$-6.5M	↑ 306.25%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$31.1M	↓ 38.42%
Investing Cash Flow	$10.7M	↓ 164.85%
Financing Cash Flow	$-47.8M	↑ 635.38%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$69.4M	↑ 123.15%
Investing Cash Flow	$-9.2M	↓ 185.98%
Financing Cash Flow	$-39.9M	↓ 16.53%

Masimo Technicals Summary

Sell

Neutral

Buy

Masimo is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Masimo Corp Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Masimo Corp	-9.09%	-26.66%	22.62%	-4.35%	-37.49%
Medtronic Plc	3.87%	-1.59%	4.32%	4.82%	-13.69%
Edwards Lifesciences Corp.	2.55%	13.95%	18.33%	-9.73%	-5.31%
Boston Scientific Corp.	0.09%	0.6%	30.02%	157.38%	154.4%
Stryker Corporation	3.63%	-0.85%	8.87%	89.43%	97.71%
Abbott Laboratories	5.15%	-5.37%	15.72%	26.56%	24.53%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Masimo Corp	116.14	NA	4.73	5.33	-0.22	0.02	NA	19.2
Medtronic Plc	25.4	25.4	2.14	5.46	0.1	0.05	0.03	37.36
Edwards Lifesciences Corp.	34.03	34.03	4.85	2.5	0.16	0.08	NA	17.94
Boston Scientific Corp.	62.95	62.95	1.84	2.98	0.12	0.05	NA	15.14
Stryker Corporation	51.54	51.54	2.24	13.49	0.14	0.08	0.01	55.43
Abbott Laboratories	16.64	16.64	4.17	5.14	0.31	0.07	0.02	29.05

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Masimo Corp	Buy	$7.7B	-37.49%	116.14	-21.32%
Medtronic Plc	Buy	$118.0B	-13.69%	25.4	13.63%
Edwards Lifesciences Corp.	Buy	$47.8B	-5.31%	34.03	72.96%
Boston Scientific Corp.	Buy	$156.7B	154.4%	62.95	13.55%
Stryker Corporation	Buy	$149.0B	97.71%	51.54	12.25%
Abbott Laboratories	Buy	$230.9B	24.53%	16.64	32.43%

About Masimo Corp

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arterial oxygen saturation, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow respiratory support therapy, neuromodulation technology, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Organization	Masimo
Employees	3600
CEO	Ms. Catherine M. Szyman
Industry	Health Technology

Key Management of Masimo Corp

Name	Title
Ms. Catherine M. Szyman	CEO & Director
Mr. Anand Sampath	Executive Vice President of Operations
Mr. Paul Hataishi	Senior VP & Chief Accounting Officer
Mr. Omar Ahmed	Chief Technology & Innovation Officer
Mr. Yongsam Lee	Executive VP & Chief Information Officer
Dr. Steven J. Barker	Chairman of Scientific Advisory Board & Chief Science Officer
Mr. Eli Kammerman	Vice President of Business Development & Investor Relations
Mr. Tim Benner	Chief Marketing & Strategy Officer
Ms. Elisabeth A. Hellmann	Chief Human Resources Officer
Dr. Huimin Wang M.D.	President of Japan & Asia Pacific

Important FAQs about investing in MASI Stock from India :

What is Masimo share price today?

Masimo share price today is $139.57 as on August 30, 2025 at 1:29 am IST at the close of the market. Masimo share today touched a day high of $141.00 and a low of $138.91.

What is the 52 week high and 52 week low for Masimo share?

Masimo share touched a 52 week high of $194.88 and a 52 week low of $107.98. Masimo stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $139.57, lower by 28.38% versus the 52 week high.

How to invest in Masimo Stock (MASI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Masimo on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Masimo Shares that will get you 0.0107 shares as per Masimo share price of $139.57 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Masimo Stock (MASI) from India?

Indian investors can start investing in Masimo (MASI) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Masimo stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Masimo share’s latest price of $139.57 as on August 30, 2025 at 1:29 am IST, you will get 0.0716 shares of Masimo. Learn more about fractional shares .

What are the returns that Masimo has given to Indian investors in the last 5 years?

Masimo stock has given -37.49% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?